search

Pfizer CEO says ‘not at all’ in favor of US patent waiver

BRUSSELS — Pfizer CEO Albert Bourla says he is against a US-backed proposal to waive patents on COVID-19 vaccines, saying production should be ramped up in existing facilities instead.

In an interview with AFP, Bourla says his company, which developed its vaccine with German firm BioNTech, is “not at all” in favor of the call from the United States to waive patent protections for coronavirus jabs.

Pfizer CEO Albert Bourla speaks during a press conference at Pfizer’s factory in Puurs, Belgium. (John Thys/Pool/AFP)
comments
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed